03/21/2025
4:49 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:42 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
3:18 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
4:33 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
| Form 144/A | |
03/18/2025
4:22 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
| Form 144/A | |
03/18/2025
3:06 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
3:14 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
4:05 PM | Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2025
3:18 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
5:02 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:07 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ELVN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/27/2025
3:10 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
4:02 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
2:45 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
8:17 AM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
4:36 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Gupta Rishi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:38 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:39 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kunkel Lori Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:40 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Phillips Andrew John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:25 PM | Collins Helen Louise (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:27 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:28 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:29 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:32 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:33 PM | Ballal Rahul D. (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:34 PM | Bauer Jake (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:35 PM | Derynck Mika K (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
6:06 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
6:21 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:37 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
3:06 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
3:01 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
4:31 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:43 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:21 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/31/2024
4:18 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:33 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:15 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
4:18 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:28 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:46 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
Now I look stupid. Real stupid... (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
11/14/2024
4:48 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
3:24 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
4:55 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
11/13/2024
3:15 PM | Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
| Form SC 13G | |
10/30/2024
5:04 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
| Form SC 13G | |
10/22/2024
3:18 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:19 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:21 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:22 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:23 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:17 PM | Collins Helen Louise (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
5:42 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
4:27 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Heyman Richard A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
4:42 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
4:10 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Heyman Richard A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
4:17 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:57 PM | Collins Helen Louise (Reporting)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
4:00 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
4:06 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:38 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Heyman Richard A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
7:36 PM | Ballal Rahul D. (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
7:38 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
7:39 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:27 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
3:16 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
5:54 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
5:56 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
5:57 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
5:58 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:28 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Heyman Richard A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
5:43 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:44 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:45 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:47 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
6:53 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:19 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:17 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:43 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:36 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
6:48 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:49 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:32 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:32 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:15 PM | Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
6:23 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
6:25 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
6:26 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
6:22 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Now I look stupid. Real stupid... (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. |
07/31/2024
6:31 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
6:33 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:30 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:31 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Heyman Richard A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
5:12 PM | 5AM Ventures VI, L.P. (Filed by)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
| Form SC 13D/A | |
07/29/2024
4:39 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2024
3:15 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
3:08 PM | Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
6:25 PM | Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
